Researchers report that ruxolitinib, an anti-inflammatory drug used to treat to a deadly childhood immune disease, effectively reversed respiratory and multi-system…
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to…
